Aromatherapy in Management of Postoperative Nausea in Post-Bariatric Surgery Patients

Lancaster General Hospital

Status: Completed

Conditions: Bariatric Surgery Candidate; Nausea, Postoperative

Treatments: Other: Peppermint oil aromatherapy

Study type: Interventional

Funder types: Other

Identifiers

NCT03130218

2016-74-LGH

Details and patient eligibility

About

Determine the effectiveness of peppermint oil aromatherapy in relieving post-operative nausea in the bariatric surgery patient population.

Full description

Healthy weight management and use of essential oils and aromatherapy as natural interventions to manage health-related issues are significantly growing interests. One frequent intervention for healthy weight management is bariatric surgery. In the post-operative period following bariatric surgery, nausea is a common consequence. Peppermint oil aromatherapy is an effective intervention for relieving nausea and other gastrointestinal symptoms in the bariatric and surgical population. This study has multiple aims. One is to determine effectiveness of peppermint oil aromatherapy in relieving post-operative nausea in the bariatric surgery patient population. A second aim is to establish relative cost-effectiveness of peppermint oil aromatherapy versus traditional anti-emetic drug therapies. A third is to determine whether peppermint oil aromatherapy increases patient satisfaction versus anti-emetic drug therapies. This is a randomized study with control and experimental groups. The control group will receive no peppermint oil aromatherapy and only traditional anti-emetics as needed. The experimental group will receive peppermint oil aromatherapy and traditional anti-emetics as needed.

Enrollment: 204 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Bariatric surgery candidate on 7-Lime at Lancaster General Hospital
• Scheduled for laparoscopic sleeve gastrectomy and laparoscopic Roux-En-Y (RNY) procedures
• Between ages of 18 and 70
• Surgical patient of either Dr. James Ku and Dr. Joseph McPhee

Exclusion criteria

• History of excessive sensitivity to peppermint oil, allergic response to peppermint oil and who state preference against aromatherapy
• Not alert and oriented or unable to follow directions will be excluded
• Severe reactive airway disease such as asthma or chronic obstructive pulmonary disease (COPD)
• Possible exclusion for severe hypertension or atrial fibrillation

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

204 participants in 2 patient groups

Control

No Intervention group

Description:

Patients in the control group will not receive peppermint oil aromatherapy as a primary intervention for postoperative nausea and vomiting. Primary therapy for postoperative nausea and vomiting would entail standard antiemetic drug therapies. Patient monitoring and documentation would include the following: Patients in the control group will be assessed every 4 hours and as needed for nausea. All aspects of care from physician, nursing and all disciplines will be consistent with current practices in care of postoperative bariatric surgical patients.

Intervention

Experimental group

Description:

Patients in the intervention group will receive peppermint oil aromatherapy as primary treatment for postoperative nausea. Pharmacological therapy with anti-nausea drug therapies will be available as needed. All other aspects of medical, surgical and nursing care will be standard practice for pre and post-operative care related to the bariatric surgical patient. Patients in the intervention group will be assessed every 4 hours and as needed for nausea. Post-intervention, the patient will be re-assessed for level of nausea after one hour. In the event the patient refuses peppermint oil aromatherapy and requests anti-emetic drug therapies, they are able to do so.

Treatment:

Other: Peppermint oil aromatherapy